Shawn Varrin Joins the Medelis Team

Veteran Clinical Researcher Shawn Varrin Joins Medelis, a Specialty Oncology CRO, as Director, Business Development

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Shawn’s research experience, coupled with his entrepreneurial spirit, background in business and a “can-do” attitude makes him an excellent combination fit for Medelis.

Nashville, TN (PRWEB) March 06, 2014

Medelis, a specialty oncology CRO focused on phase I and phase II oncology trials in North America and Europe, today announced that it has added Shawn Varrin to its executive team.

Varrin will be focusing on business development for Medelis, working with its clinical operations team and executive team to expand Medelis' presence in the U.S., Canada and Europe.

"Shawn’s research experience, coupled with his entrepreneurial spirit, background in business and a “can-do” attitude makes him an excellent combination fit for Medelis," said Bob Bosserman, CEO of Medelis.

"I'm excited about joining the Medelis team," said Varrin. "There are a lot of midsize pharma and biotechs who need a full service offering from a team with deep oncology expertise that is small enough to work in true partnership with them. Additionally, Medelis is able to provide specialized support to those big pharmas who need specific a la carte services, so it's great to have an offering for both parts of the market."

Varrin joins the current Medelis business development team that includes Chris Romano and Donna Roach.

*******

Medelis is a full service oncology contract research organization that provides sponsors with a highly-skilled and proactive oncology clinical trial management team to design and manage phase I and II oncology trials in North America and Europe.


Contact

Attachments